Operational strategies in US cancer centers of excellence that support the successful accrual of racial and ethnic minorities in clinical trials

Operational strategies in US cancer centers of excellence that support the successful accrual of racial and ethnic minorities in clinical trials

Background: Study populations in clinical research must reflect US changing demographics, especially with the rise of precision medicine. However, racial and ethnic minority groups (REMGs) have low rates of participation in cancer clinical trials. Methods: Criteria were developed to identify cancer...

Full description

Bibliographic Details
Main Authors: Jeanne M. Regnante, Nicole Richie, Lola Fashoyin-Aje, Laura Lee Hall, Quita Highsmith, J'Aimee Louis, Kenneth Turner, Spencer Hoover, Simon Craddock Lee, Evelyn González, Erin Williams, Homer Adams, III, Coleman Obasaju, Ify Sargeant, Jovonni Spinner, Christopher Reddick, Marianne Gandee, Madeline Geday, Julie Dang, Rayneisha Watson, Moon S. Chen, Jr.
Format: Article
Language:English
Published: Elsevier 2020-03-01
Series:Contemporary Clinical Trials Communications
Online Access:http://www.sciencedirect.com/science/article/pii/S2451865420300168

Internet

http://www.sciencedirect.com/science/article/pii/S2451865420300168

Similar Items